Optimizing T Cell-Based Therapy for Glioblastoma

Evading T cell surveillance is a hallmark of cancer. Patients with solid tissue malignancy, such as glioblastoma (GBM), have multiple forms of immune dysfunction, including defective T cell function. T cell dysfunction is exacerbated by standard treatment strategies such as steroids, chemotherapy, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Karachi, Aida, Dastmalchi, Farhad, Nazarian, Saina, Huang, Jianping, Sayour, Elias J., Jin, Linchun, Yang, Changlin, Mitchell, Duane A., Rahman, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374079/
https://www.ncbi.nlm.nih.gov/pubmed/34421912
http://dx.doi.org/10.3389/fimmu.2021.705580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374079/
https://www.ncbi.nlm.nih.gov/pubmed/34421912
http://dx.doi.org/10.3389/fimmu.2021.705580

Ejemplares similares